We are live on
!
Find out more
SGAM
Smith Group Asset Management Portfolio holdings
AUM
$2.46B
Turnover
25.53%
1-Year Est. Return
57.16%
This Fund
S&P 500
This Quarter
Est. Return
+9.64%
1 Year Est. Return
+57.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.46B
AUM Growth
+$417M
(+14%)
Cap. Flow
+$178M
Cap. Flow
% of AUM
5.16%
Top 10 Holdings %
Top 10 Hldgs %
30.23%
Holding
479
New
46
Increased
204
Reduced
88
Closed
60
Avg Time Held
2
years
Top 10 Avg Time Held
0.8
years
Top 20 Avg Time Held
1.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$62.9M |
| 2 |
Salesforce
CRM
|
+$51.5M |
| 3 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$40M |
| 4 |
NetApp
NTAP
|
+$38.2M |
| 5 |
HDS
HD Supply Holdings, Inc.
HDS
|
+$30.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Home Depot
HD
|
+$47.5M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$39.7M |
| 3 |
Centene
CNC
|
+$38.3M |
| 4 |
Biogen
BIIB
|
+$35.7M |
| 5 |
Paychex
PAYX
|
+$27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.96% |
| 2 | Consumer Discretionary | 16.47% |
| 3 | Healthcare | 15.48% |
| 4 | Industrials | 13.27% |
| 5 | Financials | 9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
LOXO
201
DELISTED
Loxo Oncology, Inc
LOXO
| $422K | 0.01% |
2,430
| – | – |
2017 Q3
3 quarters
|
|
202
Dana Inc
DAN
$3.13B
| $415K | 0.01% |
20,531
+2,010
| +11% | +$47.8K |
2015 Q1
13 quarters
|
|
203
W&T Offshore
WTI
$575M
| $365K | 0.01% |
51,026
-23,870
| -32% | -$154K |
2017 Q1
5 quarters
|
|
|
PCOM
204
DELISTED
Points.com Inc. Common Shares
PCOM
| $358K | 0.01% |
+21,717
| New | +$275K |
2018 Q2
0 quarters
|
|
205
Ultragenyx Pharmaceutical
RARE
$1.45B
| $357K | 0.01% |
4,650
| – | – |
2015 Q4
10 quarters
|
|
206
Myers Industries
MYE
$1.18B
| $353K | 0.01% |
18,410
+500
| +3% | +$10.7K |
2017 Q2
4 quarters
|
|
207
DELISTED
bluebird bio
BLUE
| $350K | 0.01% |
172
| – | – |
2017 Q1
5 quarters
|
|
208
First Community Bankshares
FCBC
$922M
| $348K | 0.01% |
10,914
-1,176
| -10% | -$38.3K |
2013 Q2
20 quarters
|
|
209
DELISTED
ChemoCentryx, Inc.
CCXI
| $348K | 0.01% |
26,447
| – | – |
2016 Q4
6 quarters
|
|
210
DELISTED
Array Biopharma Inc
ARRY
| $344K | 0.01% |
20,520
+480
| +2% | +$7.63K |
2018 Q1
1 quarter
|
|
211
US Physical Therapy
USPH
$1.27B
| $336K | 0.01% |
3,503
-610
| -15% | -$56.6K |
2013 Q2
20 quarters
|
|
|
GTS
212
DELISTED
Triple-S Management Corporation
GTS
| $332K | 0.01% |
8,929
| – | – |
2017 Q3
3 quarters
|
|
213
DELISTED
Amicus Therapeutics
FOLD
| $328K | 0.01% |
20,970
+200
| +1% | +$3.02K |
2017 Q2
4 quarters
|
|
214
Tilly's
TLYS
$141M
| $324K | 0.01% |
21,355
| – | – |
2015 Q1
13 quarters
|
|
215
Movado Group
MOV
$739M
| $323K | 0.01% |
6,684
-650
| -9% | -$28.1K |
2015 Q2
12 quarters
|
|
216
American Public Education
APEI
$908M
| $319K | 0.01% |
7,576
-2,260
| -23% | -$94.5K |
2016 Q2
8 quarters
|
|
217
World Acceptance Corp
WRLD
$804M
| $317K | 0.01% |
2,860
-1,180
| -29% | -$129K |
2013 Q2
20 quarters
|
|
218
Ennis
EBF
$568M
| $302K | 0.01% |
14,822
+78
| +0.5% | +$1.48K |
2015 Q4
10 quarters
|
|
219
DELISTED
Blueprint Medicines
BPMC
| $295K | 0.01% |
4,650
+100
| +2% | +$7.96K |
2017 Q3
3 quarters
|
|
220
Ironwood Pharmaceuticals
IRWD
$593M
| $294K | 0.01% |
18,352
-12
| -0.1% | -$178 |
2016 Q1
9 quarters
|
|
|
BRSS
221
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
| $294K | 0.01% |
9,392
| – | – |
2015 Q4
10 quarters
|
|
222
Hackett Group
HCKT
$282M
| $282K | 0.01% |
17,543
+95
| +0.5% | +$1.54K |
2013 Q3
19 quarters
|
|
|
BSTC
223
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $276K | 0.01% |
6,144
+27
| +0.4% | +$1.16K |
2014 Q1
17 quarters
|
|
224
RadNet
RDNT
$5.44B
| $275K | 0.01% |
18,358
| – | – |
2017 Q4
2 quarters
|
|
225
Pathward Financial
CASH
$1.51B
| $273K | 0.01% |
8,406
| – | – |
2016 Q4
6 quarters
|
|
Similar funds
MAMU
PC
RG
DIA
Smith Group Asset Management's Q2 2018 Portfolio in Review
As of Q2 2018, Smith Group Asset Management held 479 positions worth $3.46B, up 14% from $3.04B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Smith Group Asset Management deployed $178M of net new capital in Q2 2018, opening 46 new positions and adding to 204 existing holdings. Its largest new stake was Eli Lilly: 766,348 shares worth $65.4M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Home Depot, an estimated $47.5M trimmed.
- Smith Group Asset Management's largest Q2 2018 buy was Eli Lilly: 766,348 shares worth $65.4M.
- Smith Group Asset Management added most to NetApp in Q2 2018, an estimated $38.2M increase.
- Smith Group Asset Management's biggest Q2 2018 reduction was Home Depot, cutting an estimated $47.5M.
- Smith Group Asset Management fully exited Express Scripts Holding Company in Q2 2018, selling an estimated $39.7M.
- Smith Group Asset Management's ten largest holdings make up 30% of its $3.46B portfolio in Q2 2018.
- Smith Group Asset Management opened 46 new positions and closed 60 in Q2 2018.
- Smith Group Asset Management's portfolio value rose 14% quarter-over-quarter to $3.46B.
Based on Smith Group Asset Management's 13F filing for Q2 2018, filed 1 Aug 2018.